一次抗体と二次抗体-抗-エピトープタグ、免疫測定、Cas 9 » Primary Antibodies » SARS-CoV-2 Neutralizing Antibody (5B7D7), mAb, Mouse
SARS-CoV-2 Neutralizing Antibody (5B7D7), MAb, Mouse

ELISA binding of SARS-CoV-2 Neutralizing Antibody (5B7D7), mAb, Mouse (GenScript, A02056) with recombinant SARS-CoV-2 Spike Protein S1 RBD(GenScript, Z03483) and SARS-CoV RBD.

SARS-CoV-2 Neutralizing Antibody (5B7D7), MAb, Mouse

SARS-CoV-2 Neutralizing Antibody (5B7D7), mAb, Mouse (GenScript, A02056) blocks SARS-CoV-2 wild-type and VOC RBDs binding with Human ACE2 recombinant protein by sVNT.

SARS-CoV-2 S-RBD WT (GenScript, Z03483)
SARS-CoV-2 S-RBD Alpha/B.1.1.7 (GenScript, Z03533)
SARS-CoV-2 S-RBD Beta/B.1.351 (GenScript, Z03537)
SARS-CoV-2 S-RBD Gamma/P.1 (GenScript, Z03600)
SARS-CoV-2 S-RBD Delta/B.1.617.2 (GenScript, Z03613)

SARS-CoV-2 Neutralizing Antibody (5B7D7), mAb, Mouse dilution start from 10 µg/ml.

SARS-CoV-2 Neutralizing Antibody (5B7D7), mAb, Mouse

The product is specific for SARS-CoV-2 Spike Protein S1 subunit and its RBD domain
A02056
¥64,733.00

Ask us a question
Overview
Specificity The product is specific for SARS-CoV-2 Spike Protein S1 subunit and its RBD domain
Host Species Mouse
Immunogen Recombinant SARS-CoV-2 Spike protein fragment
Conjugate Unconjugated

Applications
Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product.
Application Recommended Usage
ELISA 0.01-0.1 µg/ml
Flow Cytometry 10 µg/ml
Surrogate Virus Neutralization Test (sVNT) 1-10 µg/ml

Properties
Form Liquid
Storage Buffer 0.2 μm filtered solution in PBS, pH 7.4.
Concentration 1 mg/ml
Storage Instructions Store at -20°C. This product is stable for 1 year upon receipt, when handled and stored as instructed. Avoid repeated freezing and thawing cycles.
Purification Protein A affinity column
Isotype Mouse IgG1,κ
Clonality Monoclonal
Clone ID 5B7D7
Note GenScript can customize this product per customer's request including product size, buffer components, etc.

Examples
  • SARS-CoV-2 Neutralizing Antibody (5B7D7), MAb, Mouse
    • SARS-CoV-2 Neutralizing Antibody (5B7D7), MAb, Mouse

    ELISA binding of SARS-CoV-2 Neutralizing Antibody (5B7D7), mAb, Mouse (GenScript, A02056) with recombinant SARS-CoV-2 Spike Protein S1 RBD(GenScript, Z03483) and SARS-CoV RBD.

  • SARS-CoV-2 Neutralizing Antibody (5B7D7), MAb, Mouse
    • SARS-CoV-2 Neutralizing Antibody (5B7D7), MAb, Mouse

    SARS-CoV-2 Neutralizing Antibody (5B7D7), mAb, Mouse (GenScript, A02056) blocks SARS-CoV-2 wild-type and VOC RBDs binding with Human ACE2 recombinant protein by sVNT.

    SARS-CoV-2 S-RBD WT (GenScript, Z03483)
    SARS-CoV-2 S-RBD Alpha/B.1.1.7 (GenScript, Z03533)
    SARS-CoV-2 S-RBD Beta/B.1.351 (GenScript, Z03537)
    SARS-CoV-2 S-RBD Gamma/P.1 (GenScript, Z03600)
    SARS-CoV-2 S-RBD Delta/B.1.617.2 (GenScript, Z03613)

    SARS-CoV-2 Neutralizing Antibody (5B7D7), mAb, Mouse dilution start from 10 µg/ml.


Background
Target Background SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2), also known as 2019-nCoV, is a positive-sense single-stranded RNA virus. It caused coronavirus disease 2019 (COVID-19). SARS-CoV-2 contains glycosylated spike (S) protein, which is composed of S1 subunit and S2 subunit. The S1 contains a receptor-binding domain (RBD) that can bind to ACE2 receptor on target cells.
Synonyms 2019-nCoV Neutralizing Antibody, mAb, Mouse

For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.